In conclusion, we have identified SNPs in the 3′-UTR of MDM4 gene among which rs4245739 and rs10900598 were associated with clinical outcome of advanced NSCLC patients treated with platinum-based chemotherapy, whereby the minor allele carriers have better overall survival and treatment response. Here, MDM4 is linked to non-small cell lung carcinoma.